Roche Diagnostics ME will focus on oncology
Dubai - "Roche is focused on Middle East with $100 million investment so far and we will invest more in this region."
Roche Diagnostics Middle East, or RDME is closely aligning itself with the UAE Vision 2021 National Agenda - to achieve a world-class healthcare system - by focusing on oncology for 2016, said Bassam Shehadeh, head of business support while launching its new facilities and state-of-the-art training centre at Jebel Ali Free Zone, or Jafza, in Dubai on Tuesday.
"Roche is focused on Middle East with $100 million investment so far and we will invest more in this region," Shehadeh told Khaleej Times at the launch event of the centre.
He said the biggest investment is building a knowledge-based economy, and transfer of technology and innovation in UAE as it is the hub for Middle East. "The company's focus will be on oncology while ensuring cancer patients enjoy better standard of living," he said.
The new RDME facility in Jafza comprises of a new state-of-the-art training centre which would provide advanced training to healthcare professionals in UAE and the Middle East.
Moritz Hartmann, general manager, Roche Diagnostics Middle East, said Roche aims to provide innovative and reliable solutions to achieve fast and accurate results for best patient care.
"We recognise the key role played by our healthcare professionals in accurate diagnosis and testing of a disease, for a patient, at the right time and place. And in such fast-changing dynamic industry, the launch of this new centre showcases our commitment to deliver the highest standards," Hartmann said.
Ibrahim Mohamed Aljanahi, deputy chief executive of Jafza and chief commercial officer, said "We are confident that the new RDME office at Jafza One will add value to their business and help achieve further growth; and through the facilities, space and advanced technology, reinforce its position in the Middle East markets," Aljanahi concluded